COVID-19 Antibody Testing now available

Because the sensitivity of laboratory based serology tests and rapid point-of-care tests are too low within the first 14 days after SARS-CoV-2 infection (causing COVID-19), reverse transcriptase-polymerase chain reaction (RT-PCR) remains the current gold standard of...

CYTOGENOMIC TESTING

Cytogenomics is used as a general term that encompasses conventional karyotyping, as well as molecular cytogenetics (fluorescence in situ hybridization-FISH), microarrays and molecular-based techniques. With advancing technologies and consequent shift towards an...

COVID-19 ANTIBODY TEST

In response to the many questions being asked of us as to when we would be able to offer antibody testing; this is a brief note of explanation as to the processes we have to follow before we may offer the tests. For suppliers of invitro diagnostic tests to sell test...

Coronavirus

PathCare now offers SARS-CoV-2 / COVID-19 testing On 31 December 2019, the World Health Organization (WHO) China country office reported a cluster of pneumonia cases in Wuhan City, Hubei Province of China. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...